Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study [Phase 4]

View source ↗

Summary

A Phase 4 non-interventional study (FOCUS) is evaluating the anti-inflammatory effects and clinical efficacy of topical water-free cyclosporin 0.1% eye drops in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporin 0.1% Eye Drops (water-free) (cyclosporine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Dry Eye Disease (DED) | Phase 4 | Status: RECRUITING